S. 2624 · 114th Congress
National Biomedical Research Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 114th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
9 cosponsors · 8 D, 1 I
9 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
This bill establishes and makes deposits to the Biomedical Innovation Fund for initiatives at the National Institutes of Health and the Food and Drug Administration for advancing medical innovation, including the Precision Medicine Initiative, the Brain Research through Advancing Innovative Neurotechnologies Initiative, and the Cancer Moonshot Initiative.
What it does: CRS summary · Introduced in Senate · Mar 3, 2016
National Biomedical Research Act
This bill establishes and makes deposits to the Biomedical Innovation Fund for initiatives at the National Institutes of Health and the Food and Drug Administration for advancing medical innovation, including the Precision Medicine Initiative, the Brain Research through Advancing Innovative Neurotechnologies Initiative, and the Cancer Moonshot Initiative.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: National Biomedical Research Act
Latest action (Mar 3, 2016): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Policy area: Health · Origin: Senate · Introduced: Mar 3, 2016
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.